K
Ka-Wing Cheng
Researcher at Shenzhen University
Publications - 121
Citations - 5565
Ka-Wing Cheng is an academic researcher from Shenzhen University. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 34, co-authored 103 publications receiving 4396 citations. Previous affiliations of Ka-Wing Cheng include The Chinese University of Hong Kong & Stony Brook University.
Papers
More filters
Journal ArticleDOI
Novel roles of hydrocolloids in foods: Inhibition of toxic maillard reaction products formation and attenuation of their harmful effects
Nana Zhang,Nana Zhang,Qian Zhou,Qian Zhou,Daming Fan,Daming Fan,Jianbo Xiao,Yueliang Zhao,Ka-Wing Cheng,Ka-Wing Cheng,Mingfu Wang,Mingfu Wang,Mingfu Wang +12 more
TL;DR: In this article, a review summarizes influencing factors (precursors, processing methods and parameters, and exogenous additives) of thermally induced toxicants (HCAs, AA and AGEs) formation, as well as inhibitory strategies emphasizing on the effects and potential inhibitory mechanism of hydrocolloids.
Journal ArticleDOI
Investigation of carbon and energy metabolic mechanism of mixotrophy in Chromochloris zofingiensis
TL;DR: In this article, a mixotrophic metabolic mechanism was identified in a mixture of photoautotrophic and heterotrophy in microalgal species, and the authors demonstrated that the intermediates of glycolysis could directly enter the chloroplast and replace RuBisCO-fixed CO2 to provide carbon sources for chloropplastic organic carbon metabolism under mixotroglobal growth.
Journal ArticleDOI
Unraveling the inhibitory effect of dihydromyricetin on heterocyclic aromatic amines formation.
TL;DR: The results indicate that DMY could be converted into myricetin during thermal processing, and both DMY and myRICetin could trap phenylacetaldehyde, a major Strecker aldehyde of phenylalanine, in a similar manner to thus inhibit the generation of PhIP.
Journal ArticleDOI
Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety
TL;DR: Phospho‐ibuprofen and phospho‐sulindac metabolism by major human cytochrome P450s (CYPs) and flavin monooxygenases (FMOs) is investigated.
Journal ArticleDOI
Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress
Liqun Huang,Chi Chun Wong,Gerardo G. Mackenzie,Yu Sun,Ka-Wing Cheng,Kvetoslava Vrankova,Ninche Alston,Nengtai Ouyang,Basil Rigas +8 more
TL;DR: It is demonstrated that PA-2 possesses potent chemotherapeutic efficacy against TNBC, and is also effective in its chemoprevention, warranting further evaluation as an anticancer agent.